Effect of Thoracic Spine Mobilization on Sympathetic Nervous Systems

January 28, 2019 updated by: Slavko Rogan, Bern University of Applied Sciences

Effect of Thoracic Spine Mobilization on Skin-blood Flow, Erythema and Sympathetic Nervous Systems

This pilot study aims to i) represents the feasibility of the study design and ii) to point out acute effects of thoracic spine mobilization on skin-blood flow, erythema and the sympathetic nervous system.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

14

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bern, Switzerland, 3008
        • Bern University of Applied Science, Department Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 30 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Healthy person between 20 and 30 years.

Description

Inclusion Criteria:

  • age 20 - 30 years
  • healthy persons

Exclusion Criteria:

  • current pain
  • blood pressure medications
  • osteoporosis
  • cardiac or neurological symptoms
  • pregnancy
  • thromobosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group A
Group A: immediate effects: T0, Grade 3 central thoracic mobilization from posterior-to-anterior on thoracic vertebrae from T5 to T12, immediate (T1), after 2 (T2), 4 (T3), 6 (T4), 8 (T5) and 10 (T6) minutes, 1 days wash-out period; T7, a grade 3 central thoracic mobilization from anterior-to-posterior on all thoracic vertebrae, immediate T8, after 2 (T9), 4 (T10), 6 (T11), 8 (T12) and 10 (T13) minutes.
Participant in prone position. Central thoracic mobilization from posterior-to-anterior.
Other Names:
  • Thoracic spine mobilization with anterior pressure
Participant in sitting position. Central thoracic mobilization from anteriors-to-posterior.
Other Names:
  • Thoracic spine mobilization with posterior pressure
Group B
Group B: immediate effects: T0, 3 central thoracic mobilization from anterior-to-posterior on thoracic vertebrae from T5 to T12, immediate (T1), after 2 (T2), 4 (T3), 6 (T4), 8 (T5) and 10 (T6) minutes, 1 days wash-out period; T7, a grade 3-4 central thoracic mobilization from posterior-to-anterior on all thoracic vertebrae, immediate T8, after 2 (T9), 4 (T10), 6 (T11), 8 (T12) and 10 (T13) minutes.
Participant in prone position. Central thoracic mobilization from posterior-to-anterior.
Other Names:
  • Thoracic spine mobilization with anterior pressure
Participant in sitting position. Central thoracic mobilization from anteriors-to-posterior.
Other Names:
  • Thoracic spine mobilization with posterior pressure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility: Adherence of recruited participants
Time Frame: Every 4 weeks up to 2 years
Defined as the number of drop-outs and presence of participants which invited. Measurement unit: number
Every 4 weeks up to 2 years
Feasibility of the investigating procedure
Time Frame: Every 4 weeks up to 2 years
Measured the burden of testing procedure. Measurement units = number and percentage
Every 4 weeks up to 2 years
Feasibility of the mobilization intervention from posterior-to-anterior on thoracic vertebrae
Time Frame: Every 4 weeks up to 2 years
Measured adverse effects as pain and harm results to participants. Measurement units = number and percentage
Every 4 weeks up to 2 years
Feasibility of the mobilization intervention from anterior-to-posterior on thoracic vertebrae
Time Frame: Every 4 weeks up to 2 years
Measured as adverse effects as pain and harm results to participants. Measurement units = number and percentage.
Every 4 weeks up to 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of heart rate variability (HRV)
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
HRV is measured as the variations of the time interval between two consecutive cardiac beats registered by means Polar watch RS800 is used to measures (HRV). Measurement unit: High frequency-band (HF-Band) and Low frequency-band (LF-Band)
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
Rate of systolic blood pressure value (mmHg)
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
Omron MIT Elite Plus is used for measuring systolic blood flow. iMeasurement units: mmHg (millimeter of mercury)
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
Rate of diastolic blood pressure value (mmHg) changes
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
Omron MIT Elite Plus is used for measuring diastolic blood pressureMeasurement units: mmHg (millimeter of mercury)
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
Rate of heartbeat frequency
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
Polar watch RS800 is used for measuring heartbeat frequency. Measurement units: beat per minute (bpm)
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
Rate of skin-blood flow variation
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
Laser doppler imaging is used for measuring microcirculatory changes. Measurement units: perfusion unit
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
Rate of erythema
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
Tristimulus surface colorimetry is used for measuring erythema. Measurement units: Erythema index
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jan Taeymans, PhD, Bern University of Applied Science, Departement Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 1, 2016

Primary Completion (ACTUAL)

December 31, 2018

Study Completion (ACTUAL)

December 31, 2018

Study Registration Dates

First Submitted

July 2, 2016

First Submitted That Met QC Criteria

July 11, 2016

First Posted (ESTIMATE)

July 14, 2016

Study Record Updates

Last Update Posted (ACTUAL)

January 29, 2019

Last Update Submitted That Met QC Criteria

January 28, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Mobilization Thoracic Spine

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Erythema

Clinical Trials on Mobilization anterior

Subscribe